Sign up
Quantellect · Congress · Issuer Profile
NYSE: THCTenet Healthcare Corporation
HealthcareMkt Cap $22.61BCongress ownership rank #1409

Tenet Healthcare Corporation Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 11 trades in Tenet Healthcare Corporation (NYSE: THC) since 2018, across 5 members, worth an estimated $129.00K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 5 buys against 6 sells, a modestly sell-led skew, with Democratic members responsible for 64% of the trades and Republican members 36%. The most recent disclosure shown was filed May 2026, and Jonathan Jackson has filed the most THC transactions among those shown, with 5. One notable disclosed move was a purchase by Jonathan Jackson on September 3, 2025, up 45.5% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Tenet Healthcare Corporation's current Quantellect Tide Score is 61 out of 100 (High Tide), Top 29% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Tenet Healthcare Corporation (THC) stock overview and the complete trade table below.

Data updated

Trades
5
Politicians
1
Filings
4
Disclosed Vol
$89.00K
Buys
2
40%
Sells
3
60%

Price & congressional trade timeline

Party breakdown

Tenet Healthcare congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
May 27, 2026Apr 20, 202637 daysSELL
$15,001 - $50,000
+42.15%Joint
May 27, 2026Apr 15, 202642 daysSELL
$1,001 - $15,000
+40.46%Spouse
Mar 12, 2026Feb 11, 202629 daysSELL
$1,001 - $15,000
+20.11%Spouse
Jan 8, 2026Dec 10, 202529 daysBUY
$15,001 - $50,000
+37.68%Joint
Oct 15, 2025Sep 3, 202542 daysBUY
$1,001 - $15,000
+45.46%Spouse
Go to

Tenet Healthcare (THC) congressional trading FAQ

Can members of Congress legally trade Tenet Healthcare (THC) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Tenet Healthcare (THC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Tenet Healthcare (THC) trades public?

Yes. Every congressional trade in Tenet Healthcare (THC) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Tenet Healthcare (THC)?

Members of Congress have disclosed 11 trades in Tenet Healthcare (THC) worth $129.00K across 5 members, according to public STOCK Act filings.

Which members of Congress have traded Tenet Healthcare (THC)?

Recent and active filers of Tenet Healthcare (THC) disclosures include Jonathan Jackson. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Tenet Healthcare (THC) more?

Across disclosed Tenet Healthcare (THC) trades, 64% were by Democrats and 36% by Republicans, led by Democrats (64%).

What is the most recent congressional Tenet Healthcare (THC) trade?

The most recent disclosed Tenet Healthcare (THC) trade was a sale by Jonathan Jackson, filed May 26, 2026.

What is Tenet Healthcare (THC)'s Tide Score?

Tenet Healthcare (THC) has a Quantellect Tide Score of 61 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewTenet Healthcare (THC) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.